Chester County News and Community Website
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial, a pivotal clinical study designed to evaluate its next-generation …
Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its participation in the upcoming Jefferies Global Healthcare Conference, which will be held in New York, NY, on …
Orchestra BioMed to Present at Jefferies Global Healthcare Conference Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) will host a satellite symposium at the Heart Rhythm Society (HRS) 2025 Annual Meeting in San Diego to spotlight its …
Orchestra BioMed to Highlight Advancements in Cardiac Therapy at HRS 2025 Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced that its atrioventricular interval modulation (AVIM) therapy has received Breakthrough Device Designation (BDD) from the U.S. Food and Drug …
Orchestra BioMed Secures FDA Breakthrough Device Designation for AVIM Therapy Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its financial results for 2024, alongside major updates on its clinical programs and corporate strategy. The company has demonstrated …
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO), a biomedical technology company pioneering high-impact therapeutic solutions, announced its participation in several key investor conferences slated for late February and …
Orchestra BioMed to Participate in Upcoming Investor Conferences Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Vivek Reddy, M.D., as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of its …
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) revealed promising new findings on its atrioventricular interval modulation (AVIM) therapy during a late-breaking presentation at the Technology and Heart Failure …
Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Christopher Cleary as an independent member of its Board of Directors, effective January 30, 2025. A …
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors Read MoreNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) this week announced its third quarter financial results for 2024, alongside significant updates on its clinical programs. The company is …
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs Read More